Eleni Korompoki

[International Journal of Stroke @IntJStroke]

🫀 Systematic review & meta-analysis of 3,981 TIA patients

🔍Pooled AF detection rate: 6.5% (95% CI 4.5–9.3%)

📈Detection rate rises with monitoring duration: 3.5% (1 day) → 19.1% (12 mo)

👆Implantable monitors detect more AF than non-invasive
https://t.co/4b4vCPhw01

[International Journal of Stroke @IntJStroke]

🫀 Systematic review & meta-analysis of 3,981 TIA patients

🔍Pooled AF detection rate: 6.5% (95% CI 4.5–9.3%)

📈Detection rate rises with monitoring duration: 3.5% (1 day) → 19.1% (12 mo)

👆Implantable monitors detect more AF than non-invasive
https://t.co/4b4vCPhw01

[International Journal of Stroke @IntJStroke]

🫀 🧠 CATCH-AF score provides a robust, interpretable, and easily applicable tool for predicting atrial fibrillation after ESUS

👉 ✅ Supports targeted & cost-effective rhythm monitoring

Read about CATCH-AF here! ⬇️
https://t.co/clol5WMqk2 @luciodanna2

[Θεραπευτική Κλινική ΕΚΠΑ / NKUA Therapeutics @UoATherapeutics]

https://t.co/74bgwTcywq

@thanosdimop
@StathisKastr
@mgavriatopoulou

[Andreas Charidimou MD, PhD @a_charidimou]

📌Inflammatory Cerebral Amyloid Angiopathies (iCAA)

**A note on nomenclature**

iCAA -☂️ encompasses 2 subtypes:

✨CAA-ri=only perivascular inflammation

💥ABRA=the true vasculitis that destroys the vessel

#MedTwitter #neurotwitter #NeuroTwitter #NeuroRad #Neurology #neuropath

[JohnNtan @johnntanasis]

3ο Πανελλήνιο Συνέδριο ΙΕΜΒΙΘΕΚ - Αμυλοείδωση και άλλα Σπάνια Αιματολογικά Νεοπλάσματα
21-23 Φεβρουαρίου 2025
Divani Caravel Hotel
@UoATherapeutics @thanosdimop
@StathisKastr @mgavriatopoulou
https://t.co/toZi6dcNSF

[Ashkan Shoamanesh @Ash_Shoamanesh]

Congrats to Ken Butcher on successfully leading the ICH-ADAPT2 RCT. Our results do not support the notion that BP lowering contributes to majority of acute/subacute DWI lesions in patients with ICH. Alternative mechanisms need to be explored. #ISC2025

[Thanh Lam "Lance" Tran @Lance_Tran_]

Dr Veltkemp presents results of the PRESTIGE-AF RCT (anticoagulation at 14d-12m after ICH) at #ISC25.

#⃣n=266pp analysis,~53% apixaban, ~20% dabigatran, ~%5 rivaroxaban, ~18% edoxaban
⬇️recurrence ischemic stroke (HR: 0.05)
⬆️ICH (HR 10.9)

mixed results😬

[Johanna Seiden, MD MPH @JohannaSeidenMD]

PRESTIGE-AF results, as presented by Roland Veltkamp
In ICH survivors with AF, DOAC use (2 weeks-1 year after ICH) prevents ischemic stroke (HR 0.05) but was not non-inferior in terms of recurrent ICH (HR 10.9)

Other ongoing Phase 3 RCTs: ENRICH-AF, ASPIRE
#ISC25 #AHA @StrokeAHA_ASA

[Maria Parekh @MariaParekh]

#ISC2025 #ISC25

Late breaking trials: PRESTIGE-AF

What were the bloody results❓❓

[Robert Regenhardt, MD, PhD @rwregen]

#PRESTIGE-AF results on #DOACs in #stroke prevention in #ICH survivors by Roland Veltkamp #ISC25 @AHAScience @StrokeAHA_ASA @SVINJournal @SVINSociety @YNIScommittee @SNISinfo

[PRESTIGE-AF @PRESTIGE_AF2020]

A PRESTIGE-AF Qualitative Study: Doctors find it challenging to decide on the best stroke prevention for their patients with AF who have had an ICH

[Nikolas Karvelas, MD @NikKarvel]

Posterior circulation stroke (PCS) has dismal prognosis and little is known about long-term trajectories. 🧠

Our latest work in @ESOstroke journal presents 10-year outcomes and predictive factors in PCS patients. 📈

Read the full article here: https://t.co/dUlkzcoY9u

[PRESTIGE-AF @PRESTIGE_AF2020]

After 7 years, today marks the last day of PRESTIGE-AF! 🎊

Results from the project will be available in the near future. Please keep an eye on this page 👉 https://t.co/ajQo2dnzEG

Thank you to everyone who has been a part of or followed along the PRESTIGE-AF journey! 🫀🧠

1/2

[PRESTIGE-AF @PRESTIGE_AF2020]

By 2050, cases may increase by 0.6%, reaching 141,200 per year, with deaths rising by 8.9%.

[PRESTIGE-AF @PRESTIGE_AF2020]

After 7 years, this week marks the last week of the PRESTIGE-AF project!

Over the next few days, we’ll be sharing highlights from the project leading up to its closure! Stay tuned…🧠

[valeria caso @caso_valeria]

@PRESTIGE_AF2020 It was an incredible journey to conclude the PRESTIGE AF. It involved hard work, a lot of fun, and new and old friends. A great team to answer an important clinical question: STARTING ANTICOAGULATION after ICH.

[PRESTIGE-AF @PRESTIGE_AF2020]

The PRESTIGE-AF will shortly be coming to an end at the end of the month! 😢
Check out our latest feature that explores our story, achievements, and next steps: https://t.co/AT3f1MwX1r

[PRESTIGE-AF @PRESTIGE_AF2020]

This week is Global AF Aware Week! 🫀
Do you know the relationship between #AtrialFibrillation and stroke?
Find out why AF is a risk factor for stroke and why it's not clear how we should treat patients who have had a stroke caused by a brain bleed who have AF #GAFAW2024

[Andreas Charidimou MD, PhD @a_charidimou]

🧵👇Cerebral Amyloid Angiopathy🩸🧠

Illustrations and tweetorials on CAA, SVD and related disorders

by @a_charidimou

#NeuroTwitter #stroke #Neurology #neuropath #stroke #dementia #Alzheimers #biomarker #brain #MedStudentTwitter #AmyloidAngiopathy #CAA #cSVD